538965 — CONCORD DRUGS Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro CapNeutral
- IN₹278.49m
- IN₹449.57m
- IN₹589.56m
- 57
- 50
- 65
- 62
Annual income statement for CONCORD DRUGS, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 518 | 481 | 513 | 514 | 590 |
| Cost of Revenue | |||||
| Gross Profit | 85 | 84.8 | 87.6 | 91.8 | 169 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 494 | 461 | 495 | 457 | 551 |
| Operating Profit | 23.9 | 19.5 | 18.8 | 56.2 | 38.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 6.39 | 4.4 | 4.57 | 42.9 | 22.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 3.24 | 4.07 | 3.28 | 32.8 | 15.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 3.24 | 4.07 | 3.28 | 32.8 | 15.9 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 3.24 | 4.07 | 3.28 | 32.8 | 15.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.412 | 0.518 | 0.375 | 0.462 | 1.82 |